Clinical trial
A Phase IIa, Randomized, Open-label, Multi-Center, Multi-Dose Study to Evaluate the Effects of ALZT-OP1a in Subjects With Mild-Moderate Stage Amyotrophic Lateral Sclerosis (ALS)
NCT04428775 is registered in ClinicalTrials.gov with AZTherapies, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IIa, Randomized, Open-label, Multi-Center, Multi-Dose Study to Evaluate the Effects of ALZT-OP1a in Subjects With Mild-Moderate Stage Amyotrophic Lateral Sclerosis (ALS)
- Lead sponsor
- AZTherapies, Inc.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- September 8, 2020
- Completion date
- October 1, 2021
- Enrollment
- 12 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.